Standard Bariatrics
Private Company
Total funding raised: $35M
Overview
Standard Bariatrics is a commercial-stage medical device company specializing in single-use surgical staplers for sleeve gastrectomy, a common weight-loss surgery. Its core innovation is the Titan SGS™ Stapler, which features the industry's longest continuous staple cutline and is specifically indicated for gastric sleeve creation, aiming to standardize the procedure and improve patient outcomes. The company, founded in 2015, was acquired by Teleflex in 2022, leveraging Teleflex's commercial scale. Its technology is supported by clinical data suggesting benefits in reducing complications like postoperative GERD and staple line bleeding.
Technology Platform
The Titan SGS™ Stapler System, a purpose-built surgical stapling platform for sleeve gastrectomy featuring a single-fire, 23cm curved jaw, graduated staple heights, and real-time feedback technology to create a consistent, symmetrical gastric pouch.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The primary competitors are the major surgical stapling divisions of Medtronic (Endo GIA™), Johnson & Johnson (Ethicon Endo-Surgery), and Intuitive Surgical. These companies offer general-purpose laparoscopic staplers used in sleeve gastrectomy but lack a device specifically indicated for the procedure. Standard Bariatrics' competitive edge is its dedicated, anatomy-specific design and clinical claims of superior consistency and outcomes.